Focus on Pancreatic Cancer
Nearly one-third of participants in the FOLFIRINOX arm of the trial had some tumor shrinkage.
Chemotherapy Regimen Extends Survival in Advanced Pancreatic Cancer
A four-drug chemotherapy regimen has produced the longest improvement in survival ever seen in a phase III clinical trial of people with metastatic pancreatic cancer, one of the deadliest types of cancer.
Surprise Finding: Pancreatic Cancers Progress Slowly
Pancreatic cancer develops and spreads much more slowly than scientists have thought, according to new research from Johns Hopkins investigators. The finding indicates that there is a potentially broad window for diagnosis and prevention of the disease.
Chemotherapy Provides Longer Survival than Enzyme Therapy for Pancreatic Cancer
In a clinical trial testing an experimental enzyme regimen against gemcitabine-based chemotherapy for advanced pancreatic cancer, people receiving chemotherapy lived an average of 9.7 months longer. The results are published in the Journal of Clinical Oncology.
